Recro Technology LLC
Records under this name other than patents Recro Technology LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,992,973 | Controlled Release Compositions Comprising a Combination of Isosorbide Dinitrate and Hydralazine Hydrochloride Formerly held Term ended Term ended Oct 31, 2025 · High confidence | Term ended | Term ended Oct 31, 2025 | High confidence |
| US 10,213,389 | Controlled Release Compositions Comprising A Combination Of Isosorbide Dinitrate And Hydralazine Hydrochloride Formerly held Term ended Term ended Oct 31, 2025 · Medium confidence | Term ended | Term ended Oct 31, 2025 | Medium confidence |
| US 8,512,727 | Nanoparticulate meloxicam formulations Formerly held Lapsed on the fee record Ended Aug 20, 2025 · High confidence | Lapsed on the fee record | Ended Aug 20, 2025 | High confidence |
| US 8,323,641 | Nanoparticulate Compositions Having Lysozyme as a Surface Stabilizer Formerly held Lapsed on the fee record Ended Dec 4, 2024 · High confidence | Lapsed on the fee record | Ended Dec 4, 2024 | High confidence |
| US 9,463,166 | Controlled Release Compositions Comprising a Combination of Isosorbide Dinitrate and Hydralazine Hydrochloride Formerly held Lapsed on the fee record Ended Oct 11, 2024 · Medium confidence | Lapsed on the fee record | Ended Oct 11, 2024 | Medium confidence |
| US 9,308,177 | Controlled Release Compositions Comprising a Combination of Isosorbide Dinitrate and Hydralazine Hydrochloride Formerly held Lapsed on the fee record Ended Apr 12, 2024 · Medium confidence | Lapsed on the fee record | Ended Apr 12, 2024 | Medium confidence |
| US 10,463,673 | Nanoparticulate Meloxicam Formulations Formerly held Term ended Term ended Feb 24, 2024 · Medium confidence | Term ended | Term ended Feb 24, 2024 | Medium confidence |
| US 10,471,067 | Nanoparticulate Meloxicam Formulations Formerly held Term ended Term ended Feb 24, 2024 · Medium confidence | Term ended | Term ended Feb 24, 2024 | Medium confidence |
| US 10,709,713 | Nanoparticulate Meloxicam Formulations Formerly held Term ended Term ended Feb 24, 2024 · Medium confidence | Term ended | Term ended Feb 24, 2024 | Medium confidence |
| US 6,908,626 | Compositions Having a Combination of Immediate Release and Controlled Release Characteristics Formerly held Term ended Term ended Dec 25, 2022 · High confidence | Term ended | Term ended Dec 25, 2022 | High confidence |